Effect of Pidotimod, a new immunostimulating agent, on some aspects of immune response. In vitro study.
Auteri
A
A
Istituto di Clinica Medica Generale e Terapia Medica, Università di Siena, Italia.
Pasqui
A L
AL
Bruni
F
F
Saletti
M
M
Di Renzo
M
M
Bova
G
G
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D003165:Complement System Proteins / Q000096:biosynthesis; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects*; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism; D010587:Phagocytosis / Q000187:drug effects; D011761:Pyrrolidonecarboxylic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D013844:Thiazoles / Q000494:pharmacology*; D053778:Thiazolidines
D000276:Adjuvants, Immunologic; D013844:Thiazoles; D053778:Thiazolidines; C064893:pidotimod; D003165:Complement System Proteins; D011761:Pyrrolidonecarboxylic Acid